Happy Thanksgiving! Save 50% on Your MarketBeat All Access Subscription.
Special Offer: Just $199
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
QQQ   282.71 (-1.47%)
AAPL   144.22 (-2.63%)
MSFT   241.76 (-2.32%)
META   108.78 (-2.36%)
GOOGL   96.05 (-1.45%)
AMZN   93.95 (+0.58%)
TSLA   182.92 (+0.03%)
NVDA   158.27 (-2.72%)
NIO   10.12 (-0.49%)
BABA   75.88 (+0.50%)
AMD   73.19 (-2.60%)
T   18.82 (-1.57%)
MU   55.75 (-4.55%)
CGC   3.40 (-7.10%)
F   13.73 (-2.49%)
GE   85.47 (-3.03%)
DIS   95.69 (-3.22%)
AMC   7.33 (-2.40%)
PYPL   79.93 (-0.19%)
PFE   49.57 (+0.73%)
NFLX   281.17 (-1.53%)
QQQ   282.71 (-1.47%)
AAPL   144.22 (-2.63%)
MSFT   241.76 (-2.32%)
META   108.78 (-2.36%)
GOOGL   96.05 (-1.45%)
AMZN   93.95 (+0.58%)
TSLA   182.92 (+0.03%)
NVDA   158.27 (-2.72%)
NIO   10.12 (-0.49%)
BABA   75.88 (+0.50%)
AMD   73.19 (-2.60%)
T   18.82 (-1.57%)
MU   55.75 (-4.55%)
CGC   3.40 (-7.10%)
F   13.73 (-2.49%)
GE   85.47 (-3.03%)
DIS   95.69 (-3.22%)
AMC   7.33 (-2.40%)
PYPL   79.93 (-0.19%)
PFE   49.57 (+0.73%)
NFLX   281.17 (-1.53%)
QQQ   282.71 (-1.47%)
AAPL   144.22 (-2.63%)
MSFT   241.76 (-2.32%)
META   108.78 (-2.36%)
GOOGL   96.05 (-1.45%)
AMZN   93.95 (+0.58%)
TSLA   182.92 (+0.03%)
NVDA   158.27 (-2.72%)
NIO   10.12 (-0.49%)
BABA   75.88 (+0.50%)
AMD   73.19 (-2.60%)
T   18.82 (-1.57%)
MU   55.75 (-4.55%)
CGC   3.40 (-7.10%)
F   13.73 (-2.49%)
GE   85.47 (-3.03%)
DIS   95.69 (-3.22%)
AMC   7.33 (-2.40%)
PYPL   79.93 (-0.19%)
PFE   49.57 (+0.73%)
NFLX   281.17 (-1.53%)
QQQ   282.71 (-1.47%)
AAPL   144.22 (-2.63%)
MSFT   241.76 (-2.32%)
META   108.78 (-2.36%)
GOOGL   96.05 (-1.45%)
AMZN   93.95 (+0.58%)
TSLA   182.92 (+0.03%)
NVDA   158.27 (-2.72%)
NIO   10.12 (-0.49%)
BABA   75.88 (+0.50%)
AMD   73.19 (-2.60%)
T   18.82 (-1.57%)
MU   55.75 (-4.55%)
CGC   3.40 (-7.10%)
F   13.73 (-2.49%)
GE   85.47 (-3.03%)
DIS   95.69 (-3.22%)
AMC   7.33 (-2.40%)
PYPL   79.93 (-0.19%)
PFE   49.57 (+0.73%)
NFLX   281.17 (-1.53%)
NASDAQ:CRSP

CRISPR Therapeutics - CRSP SEC Filings & 10K Form

$53.34
-1.65 (-3.00%)
(As of 11/28/2022 12:00 AM ET)
Add
Compare
Today's Range
$53.02
▼
$55.60
50-Day Range
$48.93
▼
$70.13
52-Week Range
$42.51
▼
$86.95
Volume
692,015 shs
Average Volume
1.50 million shs
Market Capitalization
$4.18 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$101.44

Recent CRISPR Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
11/01/2022
3:12 PM		CRISPR Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/28/2022
4:43 PM		CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/27/2022
7:36 AM		CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/18/2022
4:38 PM		CRISPR Therapeutics (Issuer)
Smith Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/12/2022
4:42 PM		CRISPR Therapeutics (Issuer)
Smith Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/12/2022
4:41 PM		CRISPR Therapeutics (Issuer)
Morrow Phuong Khanh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/12/2022
4:40 PM		CRISPR Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2022
4:42 PM		CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2022
6:48 AM		CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/31/2022
4:45 PM		CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2022
4:39 PM		CRISPR Therapeutics (Issuer)
Smith Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2022
4:37 PM		CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2022
4:36 PM		CRISPR Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2022
4:33 PM		CRISPR Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2022
7:11 AM		CRISPR Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2022
7:05 AM		CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/29/2022
4:38 PM		CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2022
5:00 PM		CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2022
4:05 PM		CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2022
7:02 AM		CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2022
4:46 PM		Behbahani Ali (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2022
4:44 PM		CRISPR Therapeutics (Issuer)
Treco Douglas A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2022
4:43 PM		CRISPR Therapeutics (Issuer)
High Katherine A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2022
4:41 PM		CRISPR Therapeutics (Issuer)
Greene John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2022
4:39 PM		CRISPR Therapeutics (Issuer)
George Simeon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2022
4:37 PM		CRISPR Therapeutics (Issuer)
Fardis Maria (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2022
4:36 PM		CRISPR Therapeutics (Issuer)
Fleming Harold Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2022
4:35 PM		Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2022
4:33 PM		CRISPR Therapeutics (Issuer)
Fardis Maria (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/24/2022
4:55 PM		CRISPR Therapeutics (Issuer)
Morrow Phuong Khanh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2022
4:41 PM		CRISPR Therapeutics (Issuer)
Morrow Phuong Khanh (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/16/2022
3:14 PM		CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2022
3:12 PM		CRISPR Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/25/2022
3:27 PM		CRISPR Therapeutics (Filer)
Form DEFA14A
04/25/2022
3:23 PM		CRISPR Therapeutics (Filer)
Form DEF 14A
09/14/2021
8:45 PM		CRISPR Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2021
8:44 PM		CRISPR Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2021
1:47 PM		ARK Investment Management LLC (Filed by)
CRISPR Therapeutics (Subject)
Form SC 13G/A
09/03/2021
7:00 PM		CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2021
7:00 PM		CRISPR Therapeutics (Issuer)
TOMSICEK MICHAEL JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2021
11:28 AM		Capital International Investors (Filed by)
CRISPR Therapeutics (Subject)
Form SC 13G/A
08/06/2021
7:00 PM		CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2021
4:21 PM		Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2021
4:54 PM		CRISPR Therapeutics (Issuer)
Novak Rodger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2021
4:44 PM		CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2021
3:41 PM		Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2021
5:23 PM		Behbahani Ali (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2021
4:39 PM		CRISPR Therapeutics (Issuer)
Treco Douglas A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2021
4:39 PM		CRISPR Therapeutics (Issuer)
High Katherine A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2021
4:38 PM		CRISPR Therapeutics (Issuer)
Greene John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2021
4:37 PM		CRISPR Therapeutics (Issuer)
George Simeon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2021
4:36 PM		Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2021
4:35 PM		CRISPR Therapeutics (Issuer)
Fleming Harold Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2021
4:32 PM		CRISPR Therapeutics (Issuer)
Fleming Harold Edward (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/11/2021
6:10 AM		CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2021
4:34 PM		CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2021
8:16 AM		CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/28/2021
3:22 PM		CRISPR Therapeutics (Filer)
Form DEFA14A
04/27/2021
3:19 PM		CRISPR Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/20/2021
6:22 AM		CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/05/2021
3:18 PM		CRISPR Therapeutics (Filer)
Form PRE 14A
03/24/2021
5:00 PM		Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2021
4:50 PM		CRISPR Therapeutics (Issuer)
TOMSICEK MICHAEL JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2021
4:49 PM		CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2021
4:47 PM		CRISPR Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2021
4:43 PM		CRISPR Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2021
4:41 PM		CRISPR Therapeutics (Issuer)
Ho Tony W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2021
4:37 PM		CRISPR Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
Form 4/A
03/09/2021
4:40 PM		CRISPR Therapeutics (Issuer)
Ho Tony W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
3:13 PM		CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2021
2:58 PM		Capital International Investors (Filed by)
CRISPR Therapeutics (Subject)
Form SC 13G/A
02/16/2021
6:33 AM		CRISPR Therapeutics (Subject)
Versant Ventures IV, LLC (Filed by)
Form SC 13D/A
02/05/2021
5:10 AM		CRISPR Therapeutics (Subject)
Sumitomo Mitsui Trust Holdings, Inc. (Filed by)
Form SC 13G/A
01/20/2021
5:11 PM		CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/20/2021
5:07 PM		CRISPR Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/20/2021
5:05 PM		CRISPR Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2021
3:12 PM		CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/15/2021
3:10 PM		CRISPR Therapeutics (Filer)
Form 424B5
01/04/2021
3:12 PM		CRISPR Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2020
3:02 PM		CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2020
6:12 PM		Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2020
6:14 PM		Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
Form 4/A
12/17/2020
8:06 AM		CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/14/2020
6:11 PM		Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2020
3:05 PM		CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2020
7:16 AM		CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2020
7:12 AM		CRISPR Therapeutics (Filer)
Form 424B5
12/10/2020
3:35 PM		CRISPR Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2020
6:54 PM		Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2020
6:50 AM		CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2020
3:32 PM		CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2020
3:26 PM		CRISPR Therapeutics (Issuer)
Novak Rodger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2020
8:14 AM		CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2020
4:30 PM		Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2020
7:08 AM		CRISPR Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/28/2020
7:03 AM		CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/21/2020
7:58 AM		CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/13/2020
3:44 PM		CRISPR Therapeutics (Issuer)
Novak Rodger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/09/2020
12:51 PM		ARK Investment Management LLC (Filed by)
CRISPR Therapeutics (Subject)
Form SC 13G
10/06/2020
4:48 PM		CRISPR Therapeutics (Issuer)
TOMSICEK MICHAEL JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page (NASDAQ:CRSP) was last updated on 11/28/2022 by MarketBeat.com Staff